title: Molecular basis for oncohistone H3 recognition by SETD2 methyltransferase.
abstract: High-frequency point mutations of genes encoding histones have been identified recently as novel drivers in a number of tumors. Specifically, the H3K36M/I mutations were shown to be oncogenic in chondroblastomas and undifferentiated sarcomas by inhibiting H3K36 methyltransferases, including SETD2. Here we report the crystal structures of the SETD2 catalytic domain bound to H3K36M or H3K36I peptides with SAH (S-adenosylhomocysteine). In the complex structure, the catalytic domain adopts an open conformation, with the K36M/I peptide snuggly positioned in a newly formed substrate channel. Our structural and biochemical data reveal the molecular basis underying oncohistone recognition by and inhibition of SETD2.
authors.affiliation: MOE Key Laboratory of Protein Sciences, Beijing Advanced Innovation Center for Structural Biology, Tsinghua University, Beijing 100084, China; Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China;
authors.forename: Shuang
authors.initials: S
authors.lastname: Yang
authors.affiliation: MOE Key Laboratory of Protein Sciences, Beijing Advanced Innovation Center for Structural Biology, Tsinghua University, Beijing 100084, China; Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China; Tsinghua-Peking Joint Center for Life Sciences, Tsinghua University, Beijing 100084, China;
authors.forename: Xiangdong
authors.initials: X
authors.lastname: Zheng
authors.affiliation: Laboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, New York 10065, USA;
authors.forename: Chao
authors.initials: C
authors.lastname: Lu
authors.affiliation: Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China;
authors.forename: Guo-Min
authors.initials: GM
authors.lastname: Li
authors.affiliation: Laboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, New York 10065, USA;
authors.forename: C David
authors.initials: CD
authors.lastname: Allis
authors.affiliation: MOE Key Laboratory of Protein Sciences, Beijing Advanced Innovation Center for Structural Biology, Tsinghua University, Beijing 100084, China; Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China; Tsinghua-Peking Joint Center for Life Sciences, Tsinghua University, Beijing 100084, China; Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
authors.forename: Haitao
authors.initials: H
authors.lastname: Li
mesh_terms: D020134:Catalytic Domain; D002804:Chondroblastoma / Q000201:enzymology / Q000503:physiopathology; D003460:Crystallization; D004789:Enzyme Activation / Q000235:genetics; D004926:Escherichia coli / Q000235:genetics; D011495:Histone-Lysine N-Methyltransferase / Q000737:chemistry* / Q000378:metabolism*; D006657:Histones / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D008958:Models, Molecular; D009154:Mutation; D010455:Peptides / Q000378:metabolism; D011485:Protein Binding; D020836:Protein Structure, Quaternary; D011994:Recombinant Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D012509:Sarcoma / Q000201:enzymology / Q000503:physiopathology
chemical_list: D006657:Histones; D010455:Peptides; D011994:Recombinant Proteins; D011495:Histone-Lysine N-Methyltransferase; C587921:SETD2 protein, mouse
keywords: SETD2 methyltransferase; crystal structure, epigenetic regulation; oncohistone